Insider trading

Period: 120 months Stock: HCA Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

58 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

58 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

58 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

58 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
58 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
58 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

58 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
Sold at will 7×
$21.48M 42,877 at 501.04
57.1%
Sold half or more
5 Nov 2025
McAlevey Michael R EVP & Chief Legal & Admin Off.
Sold at will
$1.84M 3,892 at 473.79
52.7%
Sold half or more
13 May 2025
Foster Jon M EVP and COO
Sold at will
$5.80M 15,698 at 369.32
55.4%
Sold half or more
2 Feb 2024
Wasserman Chad J SVP and CIO
Sold at will
$203.45K 652 at 312.04
69.2%
Sold half or more
3 Feb 2023
Reiner Deborah M SVP - Mktg. & Communications
Sold, plan not stated
$2.05M 7,941 at 257.61
100%
Sold half or more
1 Feb 2023
Foster Jon M EVP and COO
Sold, plan not stated
$4.14M 16,424 at 251.98
60.0%
Sold half or more
28 Oct 2022
Sowell Joseph A III SVP; Chief Development Officer
Sold, plan not stated
$2.89M 12,946 at 223.18
100%
Sold half or more
28 Apr 2022
Smith Andrea B Director
Bought
$247.82K 1,160 at 213.63
108%
First buy on file
4 Jan 2022
Sowell Joseph A III SVP; Chief Development Officer
Sold, plan not stated
$5.75M 22,198 at 259.23
64.2%
Sold half or more
11 Nov 2021
Foster Jon M Group President
Sold, plan not stated 3×
$3.94M 16,294 at 241.64
100%
Sold half or more
9 Nov 2021
Englebright Jane D. SVP and Chief Nursing Officer
Sold, plan not stated
$839.69K 3,364 at 249.61
100%
Sold half or more
5 Aug 2021
Englebright Jane D. SVP and Chief Nursing Officer
Sold, plan not stated
$1.00M 4,018 at 250.12
100%
Sold half or more
2 Aug 2021
Perlin Jonathan B Pres-Clinical Operations & CMO · indirect
Sold, plan not stated 4×
$10.00M 40,000 at 250.00
100%
Sold half or more
27 Apr 2021
Perlin Jonathan B Pres-Clinical Operations & CMO
Sold, plan not stated
$7.67M 38,390 at 199.91
60.1%
Sold half or more
27 Apr 2021
Perlin Jonathan B Pres-Clinical Operations & CMO · indirect
Sold, plan not stated
$5.00M 25,000 at 200.08
100%
Sold half or more
23 Feb 2021
Englebright Jane D. SVP and Chief Nursing Officer
Sold, plan not stated 3×
$1.01M 5,751 at 174.75
62.1%
Sold half or more
19 Feb 2021
Berres Jennifer SVP & Chief Human Res. Officer
Sold, plan not stated
$1.18M 6,692 at 176.05
66.4%
Sold half or more
8 Feb 2021
Foster Jon M Group President
Sold, plan not stated
$1.09M 6,171 at 176.44
100%
Sold half or more
16 Nov 2020
Morrow J William SVP - Finance and Treasurer
Sold, plan not stated
$1.19M 7,868 at 151.75
85.3%
Sold half or more
16 Nov 2020
Paslick P. Martin SVP and CIO
Sold, plan not stated
$572.10K 3,770 at 151.75
100%
Sold half or more
13 Nov 2020
Perlin Jonathan B Pres-Clinical Operations & CMO
Sold, plan not stated
$2.54M 17,002 at 149.50
89.8%
Sold half or more
9 Nov 2020
Paslick P. Martin SVP and CIO
Sold, plan not stated
$584.58K 3,948 at 148.07
100%
Sold half or more
5 Nov 2020
RUTHERFORD BILL B CFO and EVP
Sold, plan not stated
$5.05M 36,250 at 139.33
66.0%
Sold half or more
5 Nov 2020
Berres Jennifer SVP & Chief Human Res. Officer
Sold, plan not stated
$483.26K 3,472 at 139.19
71.6%
Sold half or more
3 Nov 2020
Paslick P. Martin SVP and CIO
Sold, plan not stated
$236.43K 1,771 at 133.50
100%
Sold half or more
27 Oct 2020
Morrow J William SVP - Finance and Treasurer · indirect
Sold, plan not stated 3×
$515.49K 3,840 at 134.24
68.5%
Sold half or more
4 Feb 2020
Sowell Joseph A III SVP; Chief Development Officer
Sold, plan not stated
$3.09M 21,309 at 145.00
97.1%
Sold half or more
29 Jan 2020
Sowell Joseph A III SVP; Chief Development Officer
Sold, plan not stated
$4.51M 31,063 at 145.30
98.0%
Sold half or more
24 Dec 2019
Paslick P. Martin SVP and CIO
Sold, plan not stated
$618.60K 4,164 at 148.56
100%
Sold half or more
31 Oct 2019
Foster Jon M Group President
Sold, plan not stated
$2.58M 19,477 at 132.35
66.0%
Sold half or more
10 May 2019
Foster Jon M Group President
Sold, plan not stated 2×
$5.41M 44,281 at 122.28
71.9%
Sold half or more
12 Feb 2019
RUTHERFORD BILL B CFO and EVP
Sold, plan not stated
$5.24M 37,500 at 139.65
63.6%
Sold half or more
12 Feb 2019
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold, plan not stated
$1.17M 8,368 at 139.47
66.4%
Sold half or more
14 Feb 2018
Hall Charles J Group President
Sold, plan not stated 2×
$11.98M 119,637 at 100.14
74.2%
Sold half or more
6 Feb 2018
Morgan Sandra L. SVP-Provider Relations
Sold, plan not stated
$358.36K 3,698 at 96.91
70.3%
Sold half or more
2 Feb 2018
Reiner Deborah M SVP - Mktg. & Communications
Sold, plan not stated
$664.58K 6,545 at 101.54
100%
Sold half or more
2 Feb 2018
Chari Ravi S. SVP-Clinical Excellence
Sold, plan not stated
$581.66K 5,702 at 102.01
100%
Sold half or more
2 Feb 2018
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold, plan not stated
$504.66K 5,000 at 100.93
74.2%
Sold half or more
1 Feb 2018
Sowell Joseph A III SVP; Chief Development Officer
Sold, plan not stated 2×
$3.05M 30,195 at 101.02
84.9%
Sold half or more
1 Feb 2018
Chari Ravi S. SVP-Clinical Excellence · indirect
Sold, plan not stated
$1.02M 10,000 at 101.50
100%
Sold half or more
26 Jan 2018
Sowell Joseph A III SVP; Chief Development Officer
Sold, plan not stated
$5.53M 58,175 at 95.00
91.5%
Sold half or more
22 Jun 2017
Perlin Jonathan B Pres-Clinical Services & CMO
Sold, plan not stated
$6.11M 71,063 at 86.00
82.7%
Sold half or more
23 May 2017
Davis Jana Joustra SVP - Mktg. & Corp. Affairs
Sold, plan not stated
$4.50M 54,689 at 82.35
67.5%
Sold half or more
17 May 2017
Morgan Sandra L. SVP-Provider Relations
Sold, plan not stated
$489.39K 5,915 at 82.74
71.0%
Sold half or more
17 May 2017
Torres Kathryn A. SVP- Employer&Payer Engagement
Sold, plan not stated
$142.15K 1,729 at 82.21
75.7%
Sold half or more
4 May 2017
FRIST PATRICIA C 10% owner · indirect
Bought 3×
$10.00M 120,600 at 82.92
72.2%
First buy on file
4 May 2017
FRIST THOMAS F JR 10% owner
Bought 3×
$10.00M 120,600 at 82.92
72.2%
First buy on file
27 Mar 2017
Chari Ravi S. SVP-Clinical Excellence
Sold, plan not stated
$2.88M 31,956 at 90.00
95.9%
Sold half or more
9 Feb 2017
Paslick P. Martin SVP and CIO
Sold, plan not stated
$1.88M 22,524 at 83.50
97.2%
Sold half or more
7 Feb 2017
STEELE JOHN M SVP - Human Resources
Sold, plan not stated
$2.60M 31,535 at 82.55
59.1%
Sold half or more
Showing 1–50 of 58. Page 1 of 2 Older →